选择地区语言
Through deep sequencing technology, minimal residual disease (MRD) is detected, enabling effective assessment of tumor recurrence status. MRD is the main cause of recurrence after tumor treatment. Tumor cells continuously release ctDNA into the bloodstream during processes like metastasis and apoptosis, but the overall proportion is extremely low (typically less than 0.1% in early-stage patients)—this requires the high sensitivity of molecular detection.
Platform Advantages
SE75 sequencing takes only 4.5 h, the competitive sequencing speed will keep your project running more smoothly.
Sequencers, flow cells and reagents are self-developed and produced in-house, ensuring reliable delivery.
Building on the company’s years of expertise in microbiology, this platform includes a database of over 20,000 microbial species.
Compatible with mainstream libraries on the market, eliminating debugging costs.
Sikun Integrated NGS Solution
Integrates Extraction, Library Construction, and Quality Control in One System.
Eliminates Tedious Operational Procedures, Ultra-Simple Operation.
Reduces analysis time to accelerate
critical clinical and research decisions.
